Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 2 trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 4 Country / region: Poland Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20062
20071
20092
20103
20113
20121
20132
20143
20152
20181
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
Eli Lilly and Company4
AstraZeneca2
Boehringer Ingelheim2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Sanofi2
Bristol-Myers Squibb1
Eisai Inc.1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 228
Diabetes Mellitus10
Cardiovascular Diseases2
Coronary Artery Disease2
Insulin Resistance2
Albuminuria1
Angina Pectoris1
Dyslipidemias1
Heart Failure1
Hyperlipidemias1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.